Evidence map›Paper›PMID 26861937›Full record

ArticleBMJ open2016

Association of ACE gene D polymorphism with left ventricular hypertrophy in patients with diastolic heart failure: a case-control study.

Ehsan Bahramali, Mona Rajabi, Javad Jamshidi, Seyyed Mohammad Mousavi, Mehrdad Zarghami, Alireza Manafi, Negar Firouzabadi

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Association of ACE gene polymorphism with cardiovascular determinants of trained and untrained Iranian men.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2019
    Article
  14. Article
  15. Article
  16. Review
  17. Medical journal of the Islamic Republic of Iran · 2018
    Article
  18. Article
  19. Article
  20. Molecular Approaches in HFpEF: MicroRNAs and iPSC-Derived Cardiomyocytes.Journal of cardiovascular translational research · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ehsan BahramaliNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran Cardiology Departments, Fasa University of Medical Sciences, Fasa, Iran.
Mona RajabiNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
Javad JamshidiNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran Medical Genetics Department, Fasa University of Medical Sciences, Fasa, Iran.ORCID http://orcid.org/0000-0002-6607-418X
Seyyed Mohammad MousaviNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
Mehrdad ZarghamiNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
Alireza ManafiNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
Negar FirouzabadiPharmacology and Toxicology Department, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Fasa University of Medical Sciences · IRShiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo explore the association between ACE gene insertion/deletion (I/D) polymorphism with left ventricular hypertrophy (LVH) in patients with hypertension who have developed heart failure with preserved ejection fraction (HFpEF). Being a major contributor to the development of diastolic heart dysfunction, the renin angiotensin aldosterone system and its genetic variations are thought to induce LVH in hypertensive hearts apart from haemodynamic factors.

designCase control study.

settingAn Iranian referral university hospital.

participants176 patients with hypertension and a diagnosis of HFpEF on presence of symptoms of heart failure plus Doppler echocardiographic documentation of left ventricular (LV) diastolic dysfunction and/or elevated NT-proBNP levels. Those with significant coronary, valvular, pericardial and structural heart diseases were excluded as well as patients with atrial fibrillation, renal failure and pulmonary causes of dyspnoea. They were divided into two cohorts of 88 cases with and 88 controls without LVH, after determination of LV mass index, using two-dimensional and M-mode echocardiography. The I/D polymorphism of the ACE gene was determined using the PCR method.

resultsThe D allele was significantly more prevalent among cases with compared with controls without LVH (p=0.0007). Genotype distributions also differed significantly under additive (p=0.005, OR=0.53, 95% CI 0.34 to 0.84) and recessive (p=0.001, OR=0.29, 95% CI 0.13 to 0.66) models.

conclusionsIn patients with hypertension who develop HFpEF, the D allele of the ACE gene is probably associated with the development of LVH. With the detrimental effects of LVH on the heart's diastolic properties, this can signify the role of genetic contributors to the development of HFpEF in patients with hypertension and may serve as a future risk predictor for the disease.

Indexed as

Case-Control StudiesFemaleHeart Failure, DiastolicHumansHypertrophy, Left VentricularIranMaleMiddle AgedPeptidyl-Dipeptidase APolymorphism, GeneticACE protein, humanPeptidyl-Dipeptidase AACEHeart failure with preserved ejection fractionPolymorphism

Identifiers

PMID26861937
PMCPMC4762084
OpenAlexW2264454718

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.